Pathogenic epitopes, heterologous immunity and vaccine design
Copyright policy )Pathogenic epitopes, heterologous immunity and vaccine design
Substantial research has been directed towards the development of a new generation of vaccines that are based on the inclusion of immunogenic epitopes in recombinant vectors. Here we examine the evidence that under certain conditions immunogenic epitopes can do more harm than good and might therefore be considered pathogenic. We suggest that the specific removal of such pathogenic epitopes from vaccines might increase their prophylactic potential, while minimizing the risk of side-effects from vaccine use.
- University of Utah United States
- University of Massachusetts Medical School United States
Adult, Adolescent, Immunodominant Epitopes, Epitopes, T-Lymphocyte, Viral Vaccines, Cross Reactions, Article, Mice, Inbred C57BL, Mice, Virus Diseases, Child, Preschool, Drug Design, Viruses, Animals, Humans, Child
Adult, Adolescent, Immunodominant Epitopes, Epitopes, T-Lymphocyte, Viral Vaccines, Cross Reactions, Article, Mice, Inbred C57BL, Mice, Virus Diseases, Child, Preschool, Drug Design, Viruses, Animals, Humans, Child
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).89 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!